Christopher Lindemann

Christopher Lindemann is an accomplished executive in pharmaceutical development, currently serving as Associate Vice President of CMC at Eli Lilly and Company. With a foundational education in Chemistry, including a B.S. and M.S. from the University of Wyoming, Christopher has held pivotal roles in various organizations, including founding Focus Pharmaceutics, LLC and serving as Senior Director, CMC Pharmaceutics at Loxo Oncology at Lilly. Prior to these roles, Christopher contributed significantly to Array BioPharma and Merck, building a strong background in research and development across the biopharmaceutical industry.